Select the literature
Invests in a focused portfolio of approximately 50 holdings consisting of companies of any capitalization identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Invests in a focused portfolio of approximately 50 holdings of primarily small cap companies identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Invests in a focused portfolio of approximately 50 holdings of primarily mid cap companies identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Primarily invests in a focused portfolio of approximately 40 holdings of mid cap companies identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Invests in a focused portfolio of approximately 50 holdings of primarily small and mid cap companies identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Invests in a focused portfolio of no more than 30 holdings of primarily mid cap growth companies with an environmental, social and governance (ESG) rating of medium or better, at the time of purchase. Seeks long-term capital appreciation.
Invests in a focused portfolio that generally holds less than 50 non-U.S. growth equity securities of companies of all market caps that are identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Primarily invests in a focused portfolio of approximately 50 growth equity securities of companies all over the world identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Invests in approximately 15 holdings of primarily smaller capitalization growth equity securities identified through our fundamental research as having attractive growth and quality characteristics.
Invests in a focused portfolio of approximately 35 holdings of primarily U.S. companies of any capitalization identified through our fundamental research as demonstrating promising growth potential. Seeks long-term capital appreciation.
Seeks long-term capital appreciation by investing primarily in the common stock of U.S. and non-U.S. companies within life sciences, with an emphasis on biotechnology companies. The identification of investment opportunities is primarily science-driven, relying heavily on biological and clinical data.
